Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
Injection site swelling Reports for Zoster Live (Zostavax)
#10 most reported symptom for this vaccine
Injection site swelling and Zoster Live (Zostavax)
Injection site swelling has been reported 12,334 times in association with Zoster Live (Zostavax) vaccination in VAERS. This represents 8.8% of all 140,312 reports for this vaccine.
Among these reports, 2 mentioned death (0.02%) and 94 involved hospitalization (0.8%).
Injection site swelling is the #10 most frequently reported symptom for Zoster Live (Zostavax) out of 2827 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
What This Means
Seeing 12,334 reports of Injection site swelling after Zoster Live (Zostavax) vaccination may seem alarming, but context is critical. With 140,312 total reports for this vaccine (representing many millions of doses), Injection site swelling appears in only 8.8% of reports.
The mortality rate among these reports is very low at 0.02%, suggesting most cases are non-fatal.
Important Context
Similarly Ranked Symptoms
Quick Facts
Related Pages
Data Source
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.